Daniel Martin Gensler, FNP

Daniel Gensler practices at Mercy Medical Group, a Service of Dignity Health Medical Foundation in Elk Grove, California.

Daniel Gensler's NPI, 1184292286, was assigned on June 15, 2021. Daniel Gensler holds California license NP95017554.

Daniel Gensler's primary practice is Mercy Medical Group, a Service of Dignity Health Medical Foundation, at 9394 Big Horn Blvd, Elk Grove, CA 95758 in Sacramento County. The practice phone is (916) 733-3397.

Daniel Gensler's primary practice is Mercy Medical Group, a Service of Dignity Health Medical Foundation in Elk Grove, California. Daniel Gensler is also affiliated with Dignity Health - Sierra Nevada Memorial Hospital. The medical group on file is Mercy Medical Group. Dmand AI also links Daniel Gensler to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Gensler practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Daniel Gensler's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Daniel Gensler is licensed in California.

Dmand AI lists rash among the conditions Daniel Gensler treats.

CMS data shows 2,545 Medicare services from Daniel Gensler across 18 procedure codes in 2024, for 853 Medicare patients. Medicare paid $130,532 for them. Every service was in an office.

CMS counts 853 Medicare patients who saw Daniel Gensler in 2024. The largest group is 75 to 84, with 367 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daniel Gensler's median patient age at 77, with 38% women.

In 2024, Daniel Gensler wrote 1,445 Medicare Part D claims for 424 patients. 57% of them were for generic drugs. CMS names the drug for 1,301 of them, across 18 drugs with 11 or more claims each, at $726,214 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Daniel Gensler for performance year 2024, reported through an alternative payment model (APM). Daniel Gensler accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Daniel Gensler as offering telehealth.

CMS Open Payments shows 59 general payments to Daniel Gensler from 7 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 82% of the total. Biosense Webster, Inc. paid the most, $1,593.